Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Degenhardt

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 30, 2019
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trialBruno Scheller, Marc-Alexander Ohlow, Sebastian Ewen, et al.
Indian Heart Journal|November 12, 2013
The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up studyUpendra Kaul, Martin Unverdorben, Ralf Degenhardt, et al.
American Heart Journal|April 8, 2003
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcomeMartin Unverdorben, Babett Sippel, Ralf Degenhardt, et al.
Circulation|June 3, 2009
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosisMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 30, 2014
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR studyMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Cardiovascular Drugs and Therapy|April 20, 2022
Results from the "Me & My Heart" (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary SyndromeFlorian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 27, 2011
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitusRosli Mohd Ali, Ralf Degenhardt, Robaayah Zambahari, et al.
Journal of the American College of Cardiology|May 30, 2020
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent RestenosisDaniele Giacoppo, Fernando Alfonso, Bo Xu, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 30, 2019
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trialBruno Scheller, Marc-Alexander Ohlow, Sebastian Ewen, et al.
Indian Heart Journal|November 12, 2013
The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up studyUpendra Kaul, Martin Unverdorben, Ralf Degenhardt, et al.
American Heart Journal|April 8, 2003
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcomeMartin Unverdorben, Babett Sippel, Ralf Degenhardt, et al.
Circulation|June 3, 2009
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosisMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 30, 2014
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR studyMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Cardiovascular Drugs and Therapy|April 20, 2022
Results from the "Me & My Heart" (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary SyndromeFlorian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 27, 2011
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitusRosli Mohd Ali, Ralf Degenhardt, Robaayah Zambahari, et al.
Journal of the American College of Cardiology|May 30, 2020
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent RestenosisDaniele Giacoppo, Fernando Alfonso, Bo Xu, et al.
Pageof 3